Inventor
LACY STEVEN
US5 patents
Patents
5 patentsUS10273211B2Apr 30, 2019
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
EXELIXIS INC17 citations84
US10159666B2Dec 25, 2018
Dosing of cabozantinib formulations
EXELIXIS INC21 citations84
US11141413B2Oct 12, 2021
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
EXELIXIS INC8 citations77
US12016854B2Jun 25, 2024
Liquid dosage forms to treat cancer
EXELIXIS INC1 citations60
US11504362B2Nov 22, 2022
Liquid dosage forms to treat cancer
EXELIXIS INC1 citations60